General Announcement::Company Statement

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-Dec-2024 18:48:38
Status
New
Announcement Sub Title
Company Statement
Announcement Reference
SG241215OTHRXPZE
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
16/12/2024 00:01:00
Description (Please provide a detailed description of the event in the box below)
EMA s CHMP recommends approval of Biocon Biologics YESINTEK biosimilar to J&J s Stelara

Attachments

BBL_SGX_CompanyStatement_15122024.pdf
Total size =377K